We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$333B
AUM Growth
-$5.65B
Cap. Flow
+$10.7B
Cap. Flow %
3.22%
Top 10 Hldgs %
17.75%
Holding
3,695
New
106
Increased
2,783
Reduced
461
Closed
115

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$727M
2
HD icon
Home Depot
HD
+$472M
3
PFE icon
Pfizer
PFE
+$362M
4
TXN icon
Texas Instruments
TXN
+$314M
5
LYB icon
LyondellBasell Industries
LYB
+$299M

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Financials 12.97%
3 Healthcare 12.01%
4 Consumer Discretionary 10.22%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
3351
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$152K ﹤0.01%
12,699
-1,574
-11% -$28.2K
SRTA
3352
Strata Critical Medical Inc
SRTA
$468M
$151K ﹤0.01%
17,729
-350
-2% -$2.46K
REI icon
3353
Ring Energy
REI
$320M
$151K ﹤0.01%
39,328
SMMT icon
3354
Summit Therapeutics
SMMT
$10.4B
$151K ﹤0.01%
61,313
+6,280
+11% +$15.8K
CVRX icon
3355
CVRx
CVRX
$147M
$150K ﹤0.01%
24,898
+3,102
+14% +$25K
LQDA icon
3356
Liquidia Corp
LQDA
$7.48B
$150K ﹤0.01%
20,793
PLSE icon
3357
Pulse Biosciences
PLSE
$2.63B
$150K ﹤0.01%
30,780
-5,314
-15% -$43.5K
QSI icon
3358
Quantum-Si Incorporated
QSI
$164M
$150K ﹤0.01%
32,018
HOFV
3359
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$148K ﹤0.01%
6,027
-109
-2% -$2.8K
CSSE
3360
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$145K ﹤0.01%
18,070
MAPS
3361
DELISTED
WM TECHNOLOGY INC A
MAPS
$141K ﹤0.01%
18,000
BOLT icon
3362
Bolt Biotherapeutics
BOLT
$7.67M
$140K ﹤0.01%
2,543
-208
-8% -$14K
NPCE icon
3363
Neuropace
NPCE
$466M
$140K ﹤0.01%
16,968
-480
-3% -$4.14K
TBIO
3364
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$140K ﹤0.01%
1,441
+574
+66% +$87K
RSVR
3365
DELISTED
Reservoir Media
RSVR
$139K ﹤0.01%
14,047
PWP icon
3366
Perella Weinberg Partners
PWP
$1.24B
$137K ﹤0.01%
14,490
NL icon
3367
NLI Holdings
NL
$286M
$136K ﹤0.01%
18,784
CTV
3368
DELISTED
Innovid Corp.
CTV
$136K ﹤0.01%
+22,477
New +$123K
INSE icon
3369
Inspired Entertainment
INSE
$184M
$135K ﹤0.01%
10,938
VIGL
3370
DELISTED
Vigil Neuroscience
VIGL
$135K ﹤0.01%
+19,198
New +$253K
CLYM
3371
Climb Bio
CLYM
$679M
$135K ﹤0.01%
16,001
-1,223
-7% -$11.4K
BDTX icon
3372
Black Diamond Therapeutics
BDTX
$99.1M
$134K ﹤0.01%
48,287
-12,026
-20% -$43.9K
EGY icon
3373
Vaalco Energy
EGY
$563M
$131K ﹤0.01%
20,055
ONCT
3374
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$131K ﹤0.01%
4,691
-793
-14% -$28.9K
ERNA icon
3375
Eterna Therapeutics
ERNA
$3.97M
$130K ﹤0.01%
8
-2
-20% -$37.9K

Similar funds

Charles Schwab's Q1 2022 Portfolio in Review

As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.

  • Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
  • Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
  • Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
  • Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
  • Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
  • Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
  • Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.